Is there clinical, epidemiological and molecular evidence for two forms of Crohn's disease?
- 1 October 1995
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 1 (7) , 343-348
- https://doi.org/10.1016/s1357-4310(95)80034-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Tumour-necrosis-factor antibody treatment in Crohn's diseaseThe Lancet, 1993
- Aetiology of Crohn's disease.Archives of Disease in Childhood, 1993
- Gene Therapy: Concepts, Current Trials, and Future DirectionsAnnual Review of Pharmacology and Toxicology, 1993
- Cytokine production in patients with inflammatory bowel disease.Gut, 1992
- Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel diseaseDigestive Diseases and Sciences, 1992
- Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.Gut, 1992
- Cyclosporin Pharmacokinetics after Intravenous and Oral Administration in Patients with Crohn's DiseaseScandinavian Journal of Gastroenterology, 1992
- Defining Protective Responses to Pathogens: Cytokine Profiles in Leprosy LesionsScience, 1991
- The Lipocortin of Colon Mucosa in Ulcerative ColitisHormone and Metabolic Research, 1990
- THE EXTRA-INTESTINAL COMPLICATIONS OF CROHNʼS DISEASE AND ULCERATIVE COLITIS: A STUDY OF 700 PATIENTSMedicine, 1976